TP53 and cancer: Our results show that treatment with ouabain caused a decrease in both mutant p53 protein expression in MDA-MB-231 and wild-type p53 in MCF10CA1 cancer cell lysates, whereas wild-type p53 in MCF10A (normal cell) lysates did not change (Figure 6).